Literature DB >> 23118214

Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial.

Andrés J M Ferreri, Silvia Govi, Markus Raderer, Antonino Mulè, Alessandro Andriani, Daniele Caracciolo, Liliana Devizzi, Fiorella Ilariucci, Stefano Luminari, Edi Viale, Leonhard Müllauer, Stefania Dell'Oro, Paolo Giorgio Arcidiacono, Maurilio Ponzoni, Caterina Patti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23118214     DOI： 10.1182/blood-2012-06-438424

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

1.  A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue.

Authors:  Hui-Jen Tsai; John Jen Tai; Li-Tzong Chen; Ming-Shiang Wu; Kun-Huei Yeh; Chung-Wu Lin; Tsang-En Wang; Hsiu-Po Wang; Fang-Jung Yu; Jyh-Ming Liou; Chin-Fu Hsiao; Tsu-Yao Cheng; Hong-Jen Yeh; Chung-Wang Ko; Ming-Jen Chen; Gin-Ho Lo; Ping-I Hsu; Cheng-Shyong Chang; Wei-Shou Hwang; Shih-Sung Chuang; Hsiao-Wei Lee; Chia-Tung Shun; Chang-Fang Chiu; Wen-Ming Wang; Ching-Yun Hsieh; Tsang-Wu Liu; Jaw-Town Lin; Sung-Hsin Kuo; Ann-Lii Cheng
Journal:  Haematologica       Date:  2019-11-14       Impact factor: 9.941

Review 2.  Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up.

Authors:  Calogero Vetro; Alessandra Romano; Irene Amico; Concetta Conticello; Giovanna Motta; Amalia Figuera; Annalisa Chiarenza; Cosimo Di Raimondo; Giorgio Giulietti; Giacomo Bonanno; Giuseppe Alberto Palumbo; Francesco Di Raimondo
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  De-escalating therapy in gastric aggressive lymphoma.

Authors:  Rosanna Cuccurullo; Silvia Govi; Andrés J M Ferreri
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 4.  Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.

Authors:  Thomas A Ollila; Adam J Olszewski
Journal:  Curr Treat Options Oncol       Date:  2018-06-21

Review 5.  'Trained immunity': consequences for lymphoid malignancies.

Authors:  Wendy B C Stevens; Mihai G Netea; Arnon P Kater; Walter J F M van der Velden
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

6.  Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.

Authors:  An Mt Van Nuffel; Vidula Sukhatme; Pan Pantziarka; Lydie Meheus; Vikas P Sukhatme; Gauthier Bouche
Journal:  Ecancermedicalscience       Date:  2015-02-24

Review 7.  Spontaneous perforation of primary gastric malignant lymphoma: a case report and review of the literature.

Authors:  Yu Ohkura; Seigi Lee; Daisuke Kaji; Yasunori Ota; Shusuke Haruta; Yasuaki Takeji; Hisashi Shinohara; Masaki Ueno; Harushi Udagawa
Journal:  World J Surg Oncol       Date:  2015-02-08       Impact factor: 2.754

8.  Histological transformation from gastric mucosa-associated lymphoid tissue lymphoma to gastric diffuse large B-cell lymphoma.

Authors:  Xiaowu Li; Qingliang Meng; Sanyuan Sun; Zhongli Zhan; Lianyu Zhang; Baochun Sun; Yizhuo Zhang
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

Review 9.  The Role of Endoscopic Ultrasound in the Diagnosis and Management of Primary Gastric Lymphoma.

Authors:  Dimitrios Schizas; Ioannis Ntanasis-Stathopoulos; Diamantis I Tsilimigras; Athanasios D Sioulas; Demetrios Moris; Eleftherios Spartalis; Ilias Scotiniotis; Ioannis S Papanikolaou
Journal:  Gastroenterol Res Pract       Date:  2017-03-16       Impact factor: 2.260

10.  Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity.

Authors:  S-H Kuo; K-H Yeh; L-T Chen; C-W Lin; P-N Hsu; C Hsu; M-S Wu; Y-S Tzeng; H-J Tsai; H-P Wang; A-L Cheng
Journal:  Blood Cancer J       Date:  2014-06-20       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.